$13.58
Price
$4.3B
Market Cap
1358.0
P/E Ratio
14.5
Forward P/E
$0.01
EPS (TTM)
—
Dividend Yield
$203M
Cash
$2.6B
Total Debt
314M
Shares Out
$6.68
$13.75
52-Week Range
Institutional Ownership of AMNEAL PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for AMNEAL PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2019-Q1 | |||||
| SELL | EXIT | — | — | $13.24 | |
| 2018-Q4 | |||||
| BUY | +53.0% | 2.4M | $32M | $18.50 | |
| 2018-Q3 | |||||
| BUY | NEW | 1.5M | $34M | $21.63 | |
Insider Trading for AMNEAL PHARMACEUTICALS INC
6 Months Insider Sentiment
Buy $0
Sell $2.2M
0
Buys
2
Sells
-2.2M
Net
0
Grants
Largest
$1.6M
Shah
$586K
Nark
$263K
Shah
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 17, 2025 | Ted C Nark | Director | SELL | 50.0K | $11.72 | $586K |
| Nov 12, 2025 | Nikita Shah | Executive Vice President | EXERCISE | 36.3K | $2.75 | $100K |
| Nov 12, 2025 | Nikita Shah | Executive Vice President | EXERCISE | 95.5K | $2.75 | $263K |
| Nov 12, 2025 | Nikita Shah | Executive Vice President | SELL | 131.9K | $11.92 | $1.6M |